tiprankstipranks
Trending News
More News >
ABIONYX Pharma SA (FR:ABNX)
:ABNX
France Market

ABIONYX Pharma SA (ABNX) Income Statement

Compare
5 Followers

ABIONYX Pharma SA Income Statement

Last quarter (Q2 2025), ABIONYX Pharma SA's total revenue was €2.12M, a decrease of -0.38% from the same quarter last year. In Q2, ABIONYX Pharma SA's net income was €-2.30M. See ABIONYX Pharma SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 4.60M€ 4.64M€ 5.25M€ 675.00K€ 0.00
Gross Profit
€ 844.00K€ 618.00K€ 636.00K€ 259.00K€ -80.00K
Operating Expenses
€ 5.31M€ 4.03M€ 4.75M€ 6.21M€ 3.50M
Depreciation and Amortization
€ 478.00K€ -160.00K€ 135.00K€ 119.00K€ 80.00K
EBITDA
€ -4.93M€ -4.84M€ -4.01M€ -7.42M€ -2.33M
Operating Income
€ -5.57M€ -3.41M€ -4.11M€ -5.95M€ -3.58M
Other Income/Expenses
€ 84.00K€ -106.00K€ -97.00K€ 130.00K€ 1.08M
Pretax Income
€ -5.47M€ -3.52M€ -4.21M€ -5.82M€ -2.50M
Net Income
€ -4.40M€ -3.52M€ -4.21M€ -5.82M€ -1.89M
Per Share Metrics
Basic EPS
€ -0.13€ -0.12€ -0.15€ -0.23€ -0.08
Diluted EPS
€ -0.13€ -0.12€ -0.15€ -0.23€ -0.08
Weighted Average Shares Outstanding
33.70M 29.35M 27.97M 24.88M 22.51M
Weighted Average Shares Outstanding (Diluted)
33.70M 29.35M 27.97M 24.88M 22.51M
Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History